Dov Moran

FOUNDER

Ron Elul

CEO

Prof. Itamar Raz

MEDICAL DIRECTOR

Assaf Dagan

VP PRODUCT

Ofer Yigdal

CHIEF PORTFOLIO OFFICER

Daniella Givon

DIGITAL THERAPEUTIC LEAD

Marco Fortino

HEAD OF PARTNERSHIPS

Remy Reinstein

SALES DIRECTOR, USA

Alberto Iore

CHIEF BUSINESS OFFICER

Tal Zimmerman

CHIEF GROWTH OFFICER

Lital Lotker-Kolan

VP FINANCE

Ariel Kahane

VP OPERATIONS

  • Rated 4.5/5 from over 300 reviews.

Interested on a Demo Now?

By requesting a demo you agree to
Doctorology Privacy Policy

Schedule a Demo

Feel free to contact us if you have any questions

For Payers

GlucoMe offers healthcare providers and insurers better high-level visibility and control over diabetes care. With GlucoMe, both quality and cost of diabetes care are easily assessed and optimized.

GlucoMe delivers

  • Always-Updated Data
    Drawing on data collected in near real-time from thousands of actual patients and caregivers, GlucoMe delivers a clearer picture of care trends – from efficacy through costs, and everything in between.GlucoMe’s advanced reporting provides individual-level patient usage, adherence, and treatment effectiveness snapshots, as well as global population, clinic, and patient group management reports. This offers payers unequalled big data insights into the real-life patient behavior patterns that directly affect the bottom line.
  • Measurable Savings, Rapid ROI
    ‍    Insurers are turning to subsidized patient smart devices in order to raise quality of care, enhance patient satisfaction, and lower health complications over the long term. However, as the population of diabetes patients continues to grow dramatically, payers also need to consider costs.GlucoMe offers a high-end feature-set at a low-end price point. Our simple yet powerful solutions deliver uncompromising accuracy, quality, simplicity of care and flexibility – together with a cost-effectiveness that delivers rapid ROI and can actually lower costs.
  • Long Term Cost Reductions
    ‍    GlucoMe’s smart end-to-end diabetes care approach helps lower long-term diabetes complications, keeping HbA1c levels in check and improving clinical outcomes. Enhanced diabetes management from GlucoMe is simply win-win for patients and payers - enhanced quality of life and lower long-term treatment expenses.